Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

591.04 -0.82 (-0.14%)
Official Closing Price Updated: 6:30 PM EST, Nov 30, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
Is Ozempic Killing Liposuction? A Stock That Could Get Hit Hard From New Weight-Loss Drugs
Ozempic, Novo Nordisk’s (NYSE: NVO) diabetes drug, is now popular for weight loss. The rise of the drug could become a major headwind for other companies that provide weight-loss services such... 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
FDA Gives Nod To Eli Lilly's First Treatment For Type Of Inflammatory Bowel Disease, To Compete With JNJ, Pfizer, AbbVie
The FDA approved Eli Lilly And Co's  
Via Benzinga
Exposures Product Safety
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story. 
Via Investor's Business Daily
Chart Of The Day: Eli Lilly - Big Profits In Big Pharma
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. 
Via Talk Markets
(LLY) - Analyzing Eli Lilly's Short Interest
Via Benzinga
This Is What Whales Are Betting On Eli Lilly
Via Benzinga
IBD's 100 Best ESG Companies For 2023
The companies on our list combine high sustainability scores and top stock ratings. 
Via Investor's Business Daily
Eli Lilly Unusual Options Activity For October 23
Via Benzinga
What 23 Analyst Ratings Have To Say About Eli Lilly
Via Benzinga
Eli Lilly Unusual Options Activity
Via Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $1,200 Today
Via Benzinga
Weight Loss Drugs Like Wegovy Would Not Impact Business - Healthcare Companies Tell Investors
Novo Nordisk A/S (NYSE: NVO) investors and analysts eagerly await the company's third-quarter results, hoping for clarity on when supply limitations for its weight-loss drug, Wegovy, in the U.S.  
Via Benzinga
Weight Loss Drugs Wegovy, Ozempic Gain Traction With Millennials, High Earners: New Survey Results
A new survey reveals the consumer segments showing the greatest interest in weight loss medications such as Ozempic, Mounjaro, and Wegovy. 
Via Benzinga
Will Eli Lilly Stock Be Worth More Than Tesla Stock by 2030?
The difference in market cap between these two companies is approximately $150 billion right now. 
Via The Motley Fool
421 Stocks Out Of The S&P 500 Are Down Since July; These 3 Bucked The Trend
Via Talk Markets
Topics Stocks
Exposures US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Pivotal Week Coming Up: Big Tech Earnings, Geopolitics, Technicals, Treasury Yield...
The upcoming quarter GDP is expected to hit 3.7% which has brought the FED dialogue to “higher rates for longer” which might lead us to a recession in 2024. So watch the yield on the 10-year TSY now at... 
Via Talk Markets
Topics Economy
Exposures Economy
3 Unstoppable Stocks to Buy Sooner Rather Than Later
Now is the time to invest in these great stocks. 
Via The Motley Fool
Is Your Weight-loss Medication Genuine? Demand For Drugs From Novo Nordisk And Eli Lilly Leads To Surge In Counterfeits
As obesity rates climb worldwide, so does the demand 
Via Benzinga
Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market?
Factset data indicates that out of the 17% of the S&P 500 companies that have reported so far, 73% have reported positive EPS surprises. 
Via Benzinga
Topics Stocks
Exposures US Equities
Average S&P 500 Stock Down 9.9% Since July Peak
The average decline of the S&P 500’s individual components since the index’s closing high on 7/31 is now at -9.9%, but many stocks are down much more than that. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Eli Lilly Says Lebrikizumab Monthly Maintenance Dosing At Two Years Demonstrated Efficacy For Patients With Eczema
Eli Lilly And Company (NYSE: LLY) said patients with moderate-to-seve 
Via Benzinga
7 Healthcare Stocks That Can Cure a Lackluster Portfolio
Take a position in these companies' stocks to achieve long-term gains and give a jolt to your investment portfolio. 
Via InvestorPlace
Two Stocks Set to Capitalize on the Surging Weight Loss Drug Trend
Several drugmakers have been thriving on the ongoing weight-loss trend, with Denmark's Novo Nordisk and Eli Lilly standing out in particular. 
Via Talk Markets
1 Market-Beating Stock to Buy Near Its 52-Week High
This stock has been firing on all cylinders -- and it isn't about to stop. 
Via The Motley Fool
4 Ways to Grow $100,000 Into $1 Million for Retirement
Investing for big-time growth doesn't have to be risky. 
Via The Motley Fool
1 Thing You'd Better Know Before You Invest in the Stocks Behind Ozempic and Mounjaro
Eli Lilly and Novo Nordisk are both battling demand issues for flagship treatments. 
Via The Motley Fool
The Next Trillion-Dollar Companies: 3 Stocks to Buy Now
The spotlight is on these three next trillion-dollar companies expected to continue growing at a rapid pace. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 7 8 9
...
55 56 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.